Back

V-A ECMO weaning with pump-controlled retrograde trial off (PCRTO) approach: an illustration of safety, benefits and feasibility

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Updates on mechanical circulatory support Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Francesca Fiorelli

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Factors associated with 30-day mortality in patients receiving mechanical circulatory support for cardiogenic shock
Miss M. Bogerd (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Direct comparison of mechanical circulatory support devices in porcine model of acute myocardial infarction complicated by ventricular septal defect and cardiogenic shock
Professor P. Ostadal (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Association between arterial oxygen tension with clinical outcomes in patients undergoing VA-ECMO support: a systematic review and dose-response meta-analysis
Mr M. Ananta (Central Jakarta, ID)
Abstract Slides Video
Presentation thumbnail
Impact of Impella5.0/5.5 use on short-term prognosis in patients with AMI-related cardiogenic shock receiving Impella-incorporated MCS in Japan
Doctor M. Nakamura (Toyama, JP)
Abstract Slides Video
Presentation thumbnail
Effectiveness of an Impella versus intra-aortic balloon pump in patients who received extracorporeal membrane oxygenation: a nationwide inpatient database study
Doctor Y. Nishimoto (Toyonaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Updates on mechanical circulatory support

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Impact of inhaled nitric oxide therapy in patients with cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation combined with Impella
thumbnail
Congress Presentation
Full percutaneous angio-guided ECLS implantation reduces major vascular complications as compared to surgical implantation.
thumbnail
Congress Presentation
Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shock

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources